Judith S Bond Selected Research

Tiopronin (Thiola)

3/2014	Meprin metalloproteases inactivate interleukin 6.
2/2013	Post-transcriptional regulation of meprin α by the RNA-binding proteins Hu antigen R (HuR) and tristetraprolin (TTP).
2/2011	Balance of meprin A and B in mice affects the progression of experimental inflammatory bowel disease.
3/2009	Disruption of the meprin alpha and beta genes in mice alters homeostasis of monocytes and natural killer cells.
1/2009	Meprin A metalloproteases enhance renal damage and bladder inflammation after LPS challenge.
11/2008	Prointerleukin-18 is activated by meprin beta in vitro and in vivo in intestinal inflammation.
3/2008	Targeted disruption of the meprin metalloproteinase beta gene protects against renal ischemia-reperfusion injury in mice.
11/2007	Human and mouse homo-oligomeric meprin A metalloendopeptidase: substrate and inhibitor specificities.
10/2005	Meprin beta metalloprotease gene polymorphisms associated with diabetic nephropathy in the Pima Indians.
10/2005	Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Judith S Bond Research Topics

Disease

10	Inflammation (Inflammations) 03/2014 - 01/2003
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2014 - 11/2007
5	Neoplasms (Cancer) 06/2005 - 01/2003
4	Diabetic Nephropathies (Diabetic Nephropathy) 11/2007 - 02/2003
2	Ischemia 10/2011 - 03/2008
2	Acute Kidney Injury (Acute Renal Failure) 01/2009 - 06/2005
2	Urinary Tract Infections (Urinary Tract Infection) 01/2009 - 06/2005
2	Neoplasm Metastasis (Metastasis) 06/2005 - 01/2005
2	Infections 06/2005 - 01/2003
2	Breast Neoplasms (Breast Cancer) 01/2005 - 01/2005
1	Cystic Fibrosis (Mucoviscidosis) 08/2014
1	Alzheimer Disease (Alzheimer's Disease) 08/2011
1	Colitis 02/2011
1	Edema (Dropsy) 01/2009
1	Reperfusion Injury 03/2008
1	Kidney Diseases (Kidney Disease) 10/2005
1	Birth Weight (Birth Weights) 02/2003

Drug/Important Bio-Agent (IBA)

14	Tiopronin (Thiola)FDA Link 03/2014 - 02/2003
14	Metalloproteases (Metalloproteinases)IBA 03/2014 - 01/2003
4	meprin AIBA 09/2013 - 01/2003
3	CytokinesIBA 03/2014 - 04/2005
3	Peptide Hydrolases (Proteases)FDA Link 02/2013 - 01/2003
2	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2005 - 01/2005
2	EnzymesIBA 01/2005 - 01/2003
2	Hormones (Hormone)IBA 01/2005 - 01/2005
2	PolyaminesIBA 01/2005 - 01/2005
2	Eflornithine (Ornidyl)FDA Link 01/2005 - 01/2005
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 08/2014
1	Interleukin-6 (Interleukin 6)IBA 03/2014
1	OccludinIBA 09/2013
1	villinIBA 10/2011
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2011
1	meprin BIBA 02/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2011
1	Dextran SulfateIBA 02/2011
1	Interleukin-18 (Interleukin 18)IBA 11/2008
1	Protein Isoforms (Isoforms)IBA 03/2008
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2005
1	Proteins (Proteins, Gene)FDA Link 10/2005
1	ReninIBA 10/2005
1	AngiotensinsIBA 10/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2005
1	Peptides (Polypeptides)IBA 04/2005
1	Extracellular Matrix ProteinsIBA 04/2005
1	Green Fluorescent ProteinsIBA 01/2005
1	OrnithineIBA 01/2005
1	PutrescineIBA 01/2005
1	ZincIBA 02/2003

Therapy/Procedure

1	Oral Administration 02/2011
1	Intraperitoneal Injections 03/2009
1	Therapeutics 10/2005
1	Drug Therapy (Chemotherapy) 01/2005
1	Treatment Delay 01/2005
1	Intravenous Injections 01/2005